Page last updated: 2024-09-04

abiraterone and Cushing's Syndrome

abiraterone has been researched along with Cushing's Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hartmann, RW; Hu, Q; Kazmaier, U; Lucas, S; Maurer, F; Yin, L	1

Other Studies

1 other study(ies) available for abiraterone and Cushing's Syndrome

Article	Year
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome. Journal of medicinal chemistry, 2012, Jul-26, Volume: 55, Issue:14 Topics: Animals; Aromatase; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Quinolones; Rats; Stereoisomerism; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Substrate Specificity	2012

Article

Year

Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.

Journal of medicinal chemistry, 2012, Jul-26, Volume: 55, Issue:14

Topics: Animals; Aromatase; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Quinolones; Rats; Stereoisomerism; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Substrate Specificity

2012